Saturday, November 26, 2022
wellness India Expo
Home Tags China

Tag: China

Heart attack diagnostics market sales create significant incremental opportunity over 2032

In the test sector, blood tests from the heart attack diagnostics market are anticipated to flourish at the quickest CAGR of 6.8% through 2032

China focuses on next-generation intranasal COVID-19 vaccines amid rising mutant strains

Several pharmaceutical companies across the world have started working on the inhaled vaccine formulations and China is also developing next-generation intranasal COVID-19 vaccines, says GlobalData....................

Pharma sector revenue to remain healthy at 8-11% in FY-2022: ICRA

Minimal impact of Covid-19 on the Indian pharmaceutical industry owing to inelastic demand for drugs coupled with continued supply of APIs/KSM from China, which accounts for 60% of industry requirement......................

Are India’s pharma regulations denting patient safety?

Experts shed light on the cause of rising Vitamin C prices and why patients end up paying a higher price for basic affordable vitamins which were otherwise available at reasonable prices earlier......................

Adequate nutrition crucial to fight COVID-19: Experts at ASSOCHAM’s ‘Illness to...

The expert panel holding discussions at the second edition of the series themed - Building Immunity Through Nutritious Food During Covid-19 stressed on the role of vitamins as part of nutrition going beyond popular proteins and carbohydrates..................

Novel Coronavirus: India reviews its preparedness

While no Coronavirus case has been detected in the country, the situation is being closely monitored at the highest level for adequate preparedness. NCDC Call Centre number (+91-11-23978046) made has been made operational.............

Outbreak of novel Coronavirus in China: India reviews its preparedness

As of today, there are no cases detected on community surveillance or contact tracing in India...............

High adoption of biologics to drive Arthritis Therapeutics market gains

Constant rise in the prices of popular drugs such as Humira and Enbrel could shift the focus of patients towards complementary and alternative therapies, thereby narrowing the growth of the arthritis therapeutics market..................

Sun Pharma & AstraZeneca enter into license agreement for novel oncology...

As per the terms of the agreement, Sun Pharma will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China...................

Tattvan E-Clinics signs MoU to offer telemedicine services in China

MoU was signed under patronage of China India Business Council and India China Pharma Trade Center............